Future Biosolutions
Future Biosolutions
Future BioSolutions' founder developed the new QuantiPhage ®coliphage test. It is currently the only rapid coliphage test to offer sensitivity and specificity equivalent to the gold standard plaque assay, and quantitative results for 100 mL samples, without sample processing or agar. QuantiPhage ®CT provides more rapid results compared to the plaque assay, and saves time in preparing and tempering agar. Our unique technology addresses the need for easy to perform and reliable coliphage analysis, to facilitate high throughput compliance testing. Please contact us for further information about our technology and test kits.
Images
Taken on 2020-12